MediWound Ltd. (MDWD:NASDAQ) closed at $11.85 on October 16, 2026, down 2.95% on the day. The stock trades 40.8% below its 52-week high of $20.03 and 0.1% above its 52-week low of $11.84. Over the past year, it lost 37.0%. MediWound Ltd. is part of the Consumer Durables sector (Specialty Chemicals).
| 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|
| -5.65% | -11.24% | -18.84% | -31.70% | -36.95% |
In 252 trading sessions since October 16, 2025, MDWD closed higher on 114 days (45%). Its best day was November 24, 2025 (+6.21%) and its worst was May 27, 2026 (-14.09%). The stock moved 10% or more in a single session 1 time.
MediWound Ltd., an integrated biopharmaceutical company, focuses on developing, manufacturing, and commercializing novel therapeutics products in Israel. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns. The company also develops EscharEx, which is in Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds. MediWound Ltd. was founded in 2000 and is headquartered in Yavne, Israel.
Find more stocks like MDWD with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.